PATENT CLAIM ANALYSIS

Application Number: 16087918
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-10
Patent Classification: ["544", "280000"]

Abstract:
The present invention belongs to the field of pharmaceutical chemistry, and relates to a substituted pyrrolopyrimidine CDK inhibitor, in particular to a compound as shown in formula I or a pharmaceutically acceptable salt or solvate thereof, as well as a preparation method thereof and a pharmaceutical composition thereof. The present invention also relates to the use of the compound and the pharmaceutical composition thereof in the preparation of a drug for treating diseases associated with CDK inhibition. The compound according to the present invention has a marked inhibitory effect on CDK, excellent drug absorption and significantly superior oral absorption effect.

Claim (Index 14):
A pharmaceutical composition, comprising the compound or a pharmaceutically acceptable salt or solvate thereof according to  claim 1 , and one or more pharmaceutically acceptable carriers or excipients.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.91071
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15566872', '13497067', '14158358', '13060154', '15546165']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7629323881602358
- 35 USC 102 Novelty (BERT): 0.534756051591023
- Combined Prediction Score: 0.7401147545033145
- Mean Citation Score: 350.99347400000005
- Max Citation Score: 367.805
- Similarity Product: 311.10673781543966

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test